🇺🇸 FDA
Patent

US 8609102

Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of ISAA or ISAB

granted A61KA61K39/40A61K45/06

Quick answer

US patent 8609102 (Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of ISAA or ISAB) held by Julius-Maximilians-Universitaet expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Julius-Maximilians-Universitaet
Grant date
Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K39/40, A61K45/06, A61P, A61P15/14